GlaxoSmithKline

Views & Analysis

Live Well: when health and opportunity knocks

Live Well brings health products to the doorsteps of rural Zambians in an innovative partnership between GSK and CARE International.

News

GSK could split amid pressure from investors - report

GlaxoSmithKline’s chairman, Philip Hampton, may be considering splitting the company amid pressure from top investors to separate the company into consumer, pharma and vaccines divisions.

News

GSK's blockbuster HIV drug linked with birth defects

Regulators issue warning after preliminary study findings

Events

Partner Content

Rational Combinations 360

Addressing key aspects across all facets of combination

News

AstraZeneca Amenities Building - Mississauga - Sept 2005
Non exclusive, unlimited time license for print & web to WZMH Architects

Blow for AZ as late stage COPD trial fails

GSK also hopes to get IL-5 drug approved in COPD

News

Mixed results from Roche's key new drugs in Q1

Lacklustre performance from GSK as results season begins

Live Well: when health and opportunity knocks

GSK could split amid pressure from investors - report

GSK's blockbuster HIV drug linked with birth defects

Rational Combinations 360

Blow for AZ as late stage COPD trial fails

Mixed results from Roche's key new drugs in Q1

Biogen, Denali pull Parkinson's drug after failed trial

Discover a new era of healthcare panel engagement: Grounded ...

GlaxoSmithKline

Editor's Picks